Robert J. Wilkinson

South African Medical Research Council — South Africa

Medicine · Health Sciences

98h-index40.7kcitations773works6.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(374), Infectious Diseases and Tuberculosis(185), Mycobacterium research and diagnosis(165), Pneumocystis jirovecii pneumonia detection and treatment(135), Diagnosis and treatment of tuberculosis(60)

Publications761 total

Pharmacokinetics of Dexamethasone in Tuberculous Meningitis
Clinical Infectious Diseases·2025Open Access
Transcript-Capture sequencing enriches mRNA of <i>Mycobacterium tuberculosis</i> from host samples
2025· 1 citedOpen Access
Optimization and Application of a T cell Antigen-Specific Activation Assay as Diagnostic and Treatment Monitoring Tool for Tuberculosis
ERJ Open Research·2025Open Access
A human YEATS4 variant confers resistance to TST and IGRA conversion despite Mycobacterium tuberculosis exposure
Genome Medicine·2025· 1 citedOpen Access
Taurine transport is a critical modulator of ionic fluxes during NLRP3 inflammasome activation
Cell Reports·2025· 2 citedOpen Access
The association of class II HLA alleles with tuberculosis-associated immune reconstitution inflammatory syndrome
PLoS Pathogens·2025· 1 citedOpen Access
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses
Journal of Infection·2025Open Access
A clinical practice guideline for tuberculous meningitis
The Lancet Infectious Diseases·2025· 10 citedOpen Access
Pharmacokinetics of dexamethasone in tuberculosis meningitis
2025Open Access
Immunomodulatory effects of atorvastatin on peripheral blood mononuclear cells infected with Mycobacterium tuberculosis
Frontiers in Immunology·2025· 4 citedOpen Access
Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial
The Lancet HIV·2025· 4 citedOpen Access
Population pharmacokinetics of pyrazinamide and isoniazid in plasma and cerebrospinal fluid from South African adults with tuberculous meningitis
Antimicrobial Agents and Chemotherapy·2025· 2 citedOpen Access
Archbishop Parker, the Bishops’ Bible (1568) and the Book of Psalms
Bulletin de l’Académie Belge pour l’Étude des Langues Anciennes et Orientales·2025Open Access
Correction: SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities
PLOS Global Public Health·2025Open Access
Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: A systematic review and meta-analysis
PLoS ONE·2025· 11 citedOpen Access
Effects of M. tuberculosis and HIV-1 infection on in vitro blood-brain barrier function
Journal of Neuroinflammation·2025· 2 citedOpen Access
Protein Kinase C δ: a critical hub regulating macrophage immunomodulatory functions during <i>Mycobacterium tuberculosis</i> infection
2025Open Access
Clinical, metabolic, and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies
Expert Opinion on Pharmacotherapy·2025· 2 citedOpen Access
Optimization and Application of a T cell Antigen-Specific Activation Assay as Diagnostic and Treatment Monitoring Tool for Tuberculosis
2025
Discordance between measures of Mycobacterium tuberculosis sensitization and type 2 diabetes mellitus in the United States (NHANES): A population-based cohort study
Journal of Infection·2025· 1 citedOpen Access
page 1 of 39Next →

Frequent Co-authors

Katalin A. Wilkinson(15), Adrian R. Martineau(9), Tolu Oni(8), Robert N. Davidson(8), Graeme Meintjes(8), Anne O’Garra(7), Gary Maartens(7), Molebogeng X. Rangaka(7), Chris Griffiths(6), Matthew Berry(5), Christine M. Graham(5), Geoffrey Pasvol(5), Suzaan Marais(4), Ajit Lalvani(4), Geoffrey E. Packe(4), Beate Kampmann(4), Zhaohui Xu(3), Virginia Pascual(3), Jacques Banchereau(3), Damien Chaussabel(3)